News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cleveland Biolabs Inc. (CBLI) Release: Cancer Prevention Research Publishes Preclinical Studies on Suppression of Breast Cancer Tumor Formation and Progression Using CBL0137


7/2/2012 9:26:41 AM

BUFFALO, N.Y., July 2, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI)and its subsidiary, Incuron, LLC, announced today that a study demonstrating that CBL0137 counteracts tumor formation in a mouse spontaneous breast cancer model was published online in Cancer Prevention Research, a peer-reviewed publication of the American Association for Cancer Research. The paper was co-authored by scientists at Roswell Park Cancer Institute and Cleveland BioLabs.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES